ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call
ICU Medical (Nasdaq: ICUI) has scheduled its third quarter 2024 earnings release and conference call for Tuesday, November 12th, 2024. The company will release results at approximately 4:00 p.m. ET and host a conference call at 4:30 p.m. ET. Investors can access the call via phone at (800) 343-5172 using conference ID 'ICUMED' or through a webcast on the company's website. A replay of the webcast will be available afterward.
ICU Medical (Nasdaq: ICUI) ha programmato la pubblicazione dei risultati del terzo trimestre 2024 e la relativa conference call per martedì 12 novembre 2024. La società rilascerà i risultati intorno alle 16:00 ET e ospiterà una conference call alle 16:30 ET. Gli investitori possono accedere alla chiamata telefonicamente al numero (800) 343-5172 utilizzando l'ID conferenza 'ICUMED', oppure tramite un webcast sul sito web dell'azienda. Una registrazione del webcast sarà disponibile in seguito.
ICU Medical (Nasdaq: ICUI) ha programado la publicación de sus resultados del tercer trimestre de 2024 y una llamada de conferencia para el martes 12 de noviembre de 2024. La empresa publicará los resultados aproximadamente a las 4:00 p.m. ET y llevará a cabo una llamada de conferencia a las 4:30 p.m. ET. Los inversores pueden acceder a la llamada por teléfono al (800) 343-5172 usando el ID de conferencia 'ICUMED' o a través de un webcast en el sitio web de la compañía. Una repetición del webcast estará disponible después.
ICU Medical (Nasdaq: ICUI)는 2024년 3분기 실적 발표 및 컨퍼런스 콜을 2024년 11월 12일 화요일로 예정했습니다. 회사는 동부 표준시로 오후 4시경에 결과를 발표하고, 오후 4시 30분에 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 (800) 343-5172로 전화하여 'ICUMED' 회의 ID를 사용하거나 회사 웹사이트에서 웹캐스트를 통해 콜에 참여할 수 있습니다. 웹캐스트의 재생은 이후에 제공될 것입니다.
ICU Medical (Nasdaq: ICUI) a prévu la publication de ses résultats du troisième trimestre 2024 et d'une conférence téléphonique pour le mardi 12 novembre 2024. L'entreprise publiera les résultats vers 16h00 ET et tiendra la conférence téléphonique à 16h30 ET. Les investisseurs peuvent accéder à l'appel par téléphone en composant le (800) 343-5172 avec l'identifiant de conférence 'ICUMED' ou via un webcast sur le site web de l'entreprise. Un enregistrement du webcast sera disponible par la suite.
ICU Medical (Nasdaq: ICUI) hat die Bekanntgabe der Ergebnisse für das dritte Quartal 2024 und eine Telefonkonferenz für Dienstag, den 12. November 2024, festgelegt. Das Unternehmen wird die Ergebnisse ungefähr um 16:00 Uhr ET veröffentlichen und um 16:30 Uhr ET eine Konferenzschalte abhalten. Investoren können an dem Anruf telefonisch unter (800) 343-5172 mit der Konferenz-ID 'ICUMED' teilnehmen oder über einen Webcast auf der Website des Unternehmens. Eine Aufzeichnung des Webcasts wird danach verfügbar sein.
- None.
- None.
SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call.
The Company will release its third quarter 2024 results on Tuesday, November 12th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, November 12th, 2024. The call can be accessed at (800) 343-5172, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
When will ICU Medical (ICUI) release Q3 2024 earnings?
How can I listen to ICU Medical's (ICUI) Q3 2024 earnings call?
What time is ICU Medical's (ICUI) Q3 2024 earnings conference call?
